OICR (Dr. R. Al-Awar)
oicr.on.ca
Innovation Type:
Therapeutics
Cancer Type:
Multiple
Funding Stage:
Proof of Concept
Fund:
Prospects
WD Repeat Platform - targeting multiple members of the essential scaffolding component of WD40 repeat domain (WDR) family with small molecules.